Please login to the form below

Not currently logged in

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients


MHRA approved the drug under the Early Access to Medicines Scheme

Merck buys Themis as part of drive for COVID-19 drugs and vaccines

Merck & Co HQDeal also adds a pipeline of vaccines for other infectious diseases as well as cancer

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

BMS buildingFinally wins approval in market dominated by rival Keytruda

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

GileadRemdesivir could speed recovery of patients with COVID-19, but hydroxychloroquine may not be safe

CEPI-backed coronavirus vaccine from Novavax starts trials

Coronavirus vaccineNVX-CoV2373 is tenth vaccine to reach human testing stage

NICE approves Roche’s Tecentriq in TNBC after revising deal

TecentriqDiscounted price deal sees immunotherapy recommended for use

AZ secures capacity for one billion coronavirus vaccine doses

Coronavirus vaccineInitial agreement to supply 400 million doses of Oxford University’s vaccine

EMA starts review of MorphoSys’ tafasitamab for lymphoma

Drug could challenge Novartis and Gilead’s CAR-T therapies if approved

Gilead, Galapagos dip on mixed ulcerative colitis data

GileadDrug may not work well enough to displace rivals

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

COVID-19 Updates and Daily News

Featured jobs


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...
The art of delivering valuable customer journeys aligned to your key messages in 2020...